AstraZeneca said earlier Thursday that it will manufacture and distribute the Oxford University vaccine worldwide, an announcement that precedes trials proving the vaccine is effective.
“It is certainly a risk to embark on the development of the vaccine, but it is now time to take these risks,” CEO Pascal Soriot told BBC radio on Thursday.
“This is a terrible crisis that we are facing and we need solutions and a vaccine is of course the number one tool we can bring to handle this. “
Soriot said they would have a good idea by June or July “of the direction of travel in terms of its potential effectiveness. “
“We will continue to work with the Oxford Vaccine Unit to make it available to patients and regulatory authorities as soon as possible,” he added.
“The agreement we have with the government and also with the Oxford group is that we will, for the time of the pandemic, provide the vaccine at cost. (Report by Kate Holton and Sarah Young; edited by Paul Sandle)